Kia Health Tech Profile
Key Indicators
- Authorised Capital ₹ 6.80 Cr
as on 02-11-2024
- Paid Up Capital ₹ 6.80 Cr
as on 02-11-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -5451.85%
(FY 2023)
- Ebitda -2948.15%
(FY 2023)
- Net Worth 6731.86%
(FY 2023)
- Total Assets 7087.10%
(FY 2023)
About Kia Health Tech
The Corporate was formerly known as Kia Biopharma Technologies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.80 Cr and a paid-up capital of Rs 6.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumant Pilgaonkar, Parag Sancheti, and Nitin Jajodia serve as directors at the Company.
- CIN/LLPIN
U24239MH2021PTC364174
- Company No.
364174
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2021
- Date of AGM
08 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kia Health Tech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumant Pilgaonkar  | Director | 19-Jul-2021 | Current |
| Parag Sancheti | Director | 19-Jul-2021 | Current |
| Nitin Jajodia | Director | 19-Jul-2021 | Current |
Financial Performance of Kia Health Tech.
Kia Health Tech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 5451.85% decrease in profit. The company's net worth Soared by an impressive increase of 6731.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kia Health Tech?
In 2023, Kia Health Tech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rubicon Consumer Healthcare Private LimitedActive 4 years 6 monthsParag Sancheti is a mutual person
Otrio Ventures Private LimitedActive 7 years 10 monthsSumant Pilgaonkar and Parag Sancheti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kia Health Tech?
Kia Health Tech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kia Health Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kia Health Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
